Short answer
LifeStance Health Group, Inc. (LFST) filed its Q2 2026 10-Q quarterly report on Aug 6, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $435M (up 26.1% year over year) with net income of $24M.
Q2 2026 key financials · XBRL
- Revenue
- $435M
- +26.1% YoY · +7.9% QoQ
- Net income
- $24M
- +722.8% YoY · +65.8% QoQ
- Operating margin
- 7.0%
Source: XBRL data from the LifeStance Health Group, Inc. (LFST) Q2 2026 10-Q on SEC EDGAR. USD.
LifeStance Health Group, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- Ownership concentration: TPG and Summit collectively owned approximately 35.4%, enabling significant influence over board composition and change-of-control decisions
- Nasdaq governance transition: Loss of “controlled company” status triggered a one-year phase-in for independent compensation and nominating committees
- Governance compliance exposure: Full independent-committee compliance required within one year of losing controlled-company status
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other LifeStance Health Group, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.